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Abstract
Genetic mechanisms underlying abnormal early neural develop-
ment in toddlers with Autism Spectrum Disorder (ASD) remain
uncertain due to the impossibility of direct brain gene expression
measurement during critical periods of early development. Recent
findings from a multi-tissue study demonstrated high expression
of many of the same gene networks between blood and brain
tissues, in particular with cell cycle functions. We explored rela-
tionships between blood gene expression and total brain volume
(TBV) in 142 ASD and control male toddlers. In control toddlers,
TBV variation significantly correlated with cell cycle and protein
folding gene networks, potentially impacting neuron number and
synapse development. In ASD toddlers, their correlations with
brain size were lost as a result of considerable changes in network
organization, while cell adhesion gene networks significantly
correlated with TBV variation. Cell cycle networks detected in
blood are highly preserved in the human brain and are upregu-
lated during prenatal states of development. Overall, alterations
were more pronounced in bigger brains. We identified 23 candi-
date genes for brain maldevelopment linked to 32 genes frequently
mutated in ASD. The integrated network includes genes that are
dysregulated in leukocyte and/or postmortem brain tissue of ASD
subjects and belong to signaling pathways regulating cell cycle G1/
S and G2/M phase transition. Finally, analyses of the CHD8 subnet-
work and altered transcript levels from an independent study of
CHD8 suppression further confirmed the central role of genes
regulating neurogenesis and cell adhesion processes in ASD brain
maldevelopment.
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Introduction
Autism Spectrum Disorder (ASD) is a heritable disorder involving
early brain maldevelopment (Courchesne et al, 2011a). The brain at
young ages is abnormal in a myriad of ways including brain over-
growth with an anterior/frontal to posterior cortical gradient in the
majority, but undergrowth in a minority, during the first years of life
(Courchesne et al, 2007); this shift upward in brain size distribution
is quantitative and not categorical. Brain weight at autopsy is also
shifted upward with heavier than the normal mean for an estimated
80% of 2–16 year olds, but lighter for a minority (Redcay &
Courchesne, 2005; Courchesne et al, 2011b). A small sample of
young ASD boys with heavy brain weight exhibited an excess of
67% neurons in the prefrontal cortex, which mediates social,
communication and cognitive development (Courchesne et al,
2011b). The excess of neurons in enlarged brains points to potential
dysregulation of mechanisms that govern cerebral cortical neuron
number during second trimester development. Indeed, gene
expression studies of prefrontal cortex in young ASD postmortem
cases report dysregulation of gene expression associated with cell
production, DNA-damage response, and apoptosis (Chow et al,
2012). Recently, alterations were detected in cell cycle timing and
excess cell proliferation in neuroprogenitor cells derived from
fibroblasts of living ASD patients who displayed early brain
overgrowth (Marchetto et al, unpublished data).
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Disrupting mechanisms regulating cell number in the second
trimester has long been theorized to play a role in brain maldevelop-
ment in ASD (Courchesne et al, 2001) because mutant mouse model
studies show that cell cycle molecular machinery governs the over-
all size of the brain (Nakayama et al, 1996; Ferguson et al, 2002).
In fact, several pathological changes characteristic of ASD were
recently modeled in mouse (WDFY3 loss of function) and displayed
abnormal decreases in cell cycle timing, excess radial glia cell prolif-
eration, prenatal brain overgrowth, and an abnormal anterolateral
to posteromedial gradient of cortical overgrowth; interestingly, it
also displays focal laminar dysplasia associated with mis-migrated
cells (Orosco et al, 2014). This latter pathology may also parallel the
report of focal prefrontal and temporal cortical laminar defects in
91% of young ASD males and females (Stoner et al, 2014).
However, additional genes are known to be associated with either
abnormal brain enlargement or reduction in animal models
(Ellegood et al, 2014) and/or rare individual ASD cases (O’Roak
et al, 2012), suggesting additional mechanisms underlying ASD.
Recent genomic analyses of high-confidence genes in ASD
(Parikshak et al, 2013; Willsey et al, 2013; De Rubeis et al, 2014)
also point to dysregulation of cortical neuron number, laminar
development, and cell cycle in the prefrontal cortex during second
and third trimesters. While each of these genes occurs only in rare
individual ASD cases, cycle cell dysregulation functions may
commonly disrupt development in the second trimester in ASD.
While many high-confidence ASD genes regulate downstream tran-
scriptional programs including cell cycle functions and proliferation,
such as CHD8, in general they are not cell cycle genes per se. This
suggests that effects of high-confidence ASD genes on cell prolifera-
tion and brain size may be quantitative and continuous and not
categorical. Many genetic and non-genetic defects could disrupt cell
cycle, with changes in signaling and transcriptional activity, which
could lead to variations in cell number and brain size. Unfortu-
nately, it remains infeasible to directly test the impact of cell cycle
changes on cell number and brain size in ASD in vivo or with
postmortem approaches. This is because cell cycle activity changes
with development, and assays that test cell cycle activity in older
postmortem tissue provide only indirect information about its
function during fetal development. Moreover, the scarcity of post-
mortem ASD cases further limit getting even indirect evidence of cell
cycle dysfunction on brain size from this avenue.
These barriers hinder the study of relationships between cell
cycle disorganization and brain size variance in ASD during early
development. However, we note that genetic disruption of cell cycle
network organization could be detectable in multiple tissues at dif-
ferent ages. While the physiological response of a genetic perturba-
tion often varies with tissue type and age, the presence of disruption
may nonetheless be detectable and quantifiable across types and
ages. That is, detection in one tissue type at one age, such as leuko-
cytes in infants, may help the search for the presence of disruption
in other inaccessible cell types and ages, such as fetal neuroprogeni-
tor cells. Of note, the GTEx Consortium reported in Science that cell
cycle gene expression networks are present in all tissues, including
brain and blood (GTEx Consortium, 2015).
Therefore, we took a systems biology approach to analyzing gene
co-expression patterns in blood leukocyte samples of ASD and
control infants and toddlers in order to examine how variation in
co-expression modules are associated with variation in brain size at
very young ages in ASD. Here, we show that gene expression pro-
files from leukocytes at very young ages may be a biomarker of
early brain growth deviance in ASD. Furthermore, we use cell cycle
networks as an entry point to elucidate perturbation of transcrip-
tional networks associated with smaller and bigger brains. Our find-
ings of network dysfunction are integrated with recent genomic
studies describing genes frequently mutated in ASD, thus providing
compelling evidence that cell cycle networks may indeed be a point
of convergence for gene expression dysregulation, mutation, and
early brain maldevelopment in ASD.
Results
We tested the hypothesis that blood-based gene expression profiling
may reveal biological signatures relevant to neurodevelopment and
that such signatures may differ between ASD and control toddlers.
Leukocyte RNA levels were analyzed in relationship to total brain
volume (TBV) using an established approach based on gene co-
expression (WGCNA; Fig 1A and B; Langfelder & Horvath, 2008).
This method elucidates patterns of altered gene expression, orga-
nized as networks of co-expressed genes, and provides insights into
relationships of genes with disease-related endophenotypes or traits.
Furthermore, it provides metrics to understand the details of
network perturbation (Langfelder & Horvath, 2007, 2008; Fig 1C).
We leveraged network metrics to understand whether network
perturbation differentially affected smaller and bigger brains in ASD
toddlers as compared to controls (Fig 1D). Lastly, we used a reverse
genetic approach to frame our findings with recent evidence from
genomic studies reporting high-confidence genes of ASD (De Rubeis
et al, 2014).
Different gene networks associate with brain size in ASD and
control toddlers
Analyses were run using processed gene expression data (Pramparo
et al, 2015) that included 12,208 unique gene-probes from 87 ASD
and 55 control male subjects ages 1–4 years. The majority of
subjects were of Caucasian origin and Pearson’s chi-squared test
showed no significant difference in race characteristics between
ASD and control (X2[5] = 7.98, P = 0.1569). Multivariate regression
analysis showed no variance explained by differences in race and
ethnicity characteristics between ASD and control subjects and age
variance was accounted in downstream analyses. Unsupervised
WGCNA resulted in 22 co-expression modules (Appendix Fig S1).
Each module was given an arbitrary color name and was summa-
rized by a metric known as the module eigengene (ME), which is
the first principal component of the module (i.e., axis capturing the
majority of variation in expression in the module). After degree-
preserving random shuffling, it was determined that all 22 modules
were significantly detected above chance levels (see Materials and
Methods and Appendix Fig S2). Module preservation analysis
between the two separate datasets (ASD/control) displayed high-
preservation scores, suggesting that the combined analysis was not
confounded by differences in networks structure of the two datasets
(Appendix Fig S3 and Appendix Table S1).
Module eigengene values from each of the 65 ASD and 38 control
subjects, who also had MRI scans, were used in linear correlation
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Figure 1. Schematic of the approach used in the study.
A Blood gene expression was analyzed in relationship with neuroanatomic measures using a co-expression network-based approach (WGCNA). The distribution of
neuroanatomic measure was normal and not significantly different between ASD and control toddlers. The analysis of co-expression was combined with all available
samples.
B Data from the combined network-based analysis was further investigated in each ASD and control group separately using a linear model.
C Network features, calculated from the WGCNA co-expression analysis in relationship to brain size, were used to dissect alterations of network patterns in ASD brains.
D Network features were also used to characterize smaller and bigger brains in each study group.
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tests in which we related RNA levels to brain size. TBV measures
were age-corrected (see Materials and Methods) and showed normal
distributions with no statistically significant differences in mean and
variance between the two groups (Fig 2A). Seven modules were
significantly correlated with TBV measures across all subjects
(FDR < 0.05) with the greenyellow and grey60 gene modules
displaying the strongest correlations (Fig 2B). Permutation analysis
with randomly generated MEs (see Materials and Methods) demon-
strated that these associations were significant against chance for all
but the yellow module (Appendix Fig S4).
To identify gene networks that correlated with brain size within
each diagnostic group, we computed Pearson’s r correlation statis-
tics between each of the seven MEs and TBV measures in ASD and
control toddlers, separately. In control toddlers, the greenyellow
and grey60 MEs were significantly correlated with age-corrected
TBV (Fig 2B), while brain size in ASD toddlers displayed significant
linear correlations with the salmon, turquoise, and cyan MEs
(Fig 2B; see Appendix Table S2 for bootstrapped 95% confidence
intervals). We restricted further analyses to only modules showing
the strongest effects on brain size (i.e. r > 0.3, P < 0.05,
FDR < 0.05), which included greenyellow, grey60, and salmon
modules. These effects were found to be independent of age
(Appendix Table S3) and confirmed to be significant against chance
after permutation analysis (Appendix Fig S5 and see Materials and
Methods). WGCNA on the separate ASD and control datasets also
confirmed that these three gene networks were the strongest signal
associated with TBV variation in each group (Appendix Figs S6 and
S7 and Dataset EV1). We next used permutation tests to examine
A B C
D E F
Figure 2. Analysis of gene networks associated with variation in brain size in ASD and control toddlers.
A Distributions of brain size as indexed by total brain volume (TBV) in ASD and control toddlers used in the co-expression analysis (WGCNA). T, value from t-test;
F, value from Levene’s test.
B Module eigengenes (MEs) from the combined WGCNA are linearly correlated with TBV measures in all brains, ASD and control groups. P-value is in parenthesis and
adjusted P-value (q-value) is < 0.05 for all seven modules. Significant associations after 10,000 permutation tests are provided in Appendix Figs S4 and S5.
C Metacore enrichment scores of the seven (7) modules initially related to brain size variation across all subjects. Each module is called by its assigned color and
represents the top process network obtained by the enrichment analysis in Metacore GeneGO (see also Dataset EV1).
D–F (i) Linear modeling of module eigengenes (MEs) by TBV measures in control (blue) and ASD (red) toddlers. See also Fig 2B for cor and P-values. (ii) Linear modeling
of GS by GC to display changes in network organization relevant to brain size. (iii) The top 30 genes with highest values for GS and GC were compared between
ASD and control. Purple indicates the number of genes that moved away from the top 30 rank position between the two groups (Different genes), and grey
indicates the number of genes that did not (Common genes). Significance codes: ***P-value < 0.001; **P-value < 0.01; cor, correlation coefficient; ns, not
significant.
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whether the strength of these correlations (MEs-TBV) significantly
differed between the two groups. However, correlations were not
significantly different between groups for greenyellow P = 0.33, but
were at or beyond trend level significance for grey60 (P = 0.06) and
salmon (P = 0.01; see Fig 2Di–Fi and Appendix Table S4).
To investigate the biological functions of these modules, we ran
pathway enrichment analysis in Metacore GeneGO using a threshold
of FDR q < 0.05. The greenyellow and grey60 modules were
enriched in genes with cell cycle and protein folding functions,
respectively, while genes in the salmon module were enriched in
cell adhesion functions (Fig 2C and Dataset EV1). This enrichment
remained significant after filtering for expression in fetal and adult
brain tissue using the Metacore GeneGo database (Dataset EV1).
The other modules with modest correlations displayed enrichment
in translation, inflammation, and cytoskeleton rearrangement func-
tions (Fig 2C and Dataset EV1).
Network perturbation in ASD affects gene connectivity and
relevance for brain size
In addition to quantifying gene module summary measures like the
module eigengene and its relationship to brain size, we also used
two gene-level metrics (gene significance and gene connectivity) to
assess associations with brain size. Gene significance (GS) is defined
as the correlation between gene expression and a trait (i.e., TBV),
thus providing a measure of “significance or relevance” of a particu-
lar gene to variation in a trait such as TBV. Gene connectivity (GC)
is a connectivity measure indicating how strongly connected (i.e.,
correlation strength) is a particular gene with all other genes within
the module. Higher GC values are indicative of central or ‘hub’
genes, whereas genes with lower GC are oriented around the periph-
ery of the co-expression module. Examining the correlation between
GC with GS values for each gene allows for insight into understand-
ing how metrics of a gene’s organization within a network (i.e. gene
connectivity) may be associated to its relevance with brain size
(i.e., gene significance).
GS-GC correlations were stronger in control compared to ASD
(i.e. more positive) in both the cell cycle (control: r = 0.64; ASD:
r = 0.42; z = 3.47) and protein folding modules, (control: r = 0.64;
ASD r = 0.40; z = 3.19) (see Fig 2Dii–Fii). Thus, as a gene becomes
more highly connected with other genes within the cell cycle and
protein folding modules, it also becomes more relevant to (or has
stronger impact on) TBV, and this relationship is stronger in control
than ASD. For the cell adhesion module, the ASD group showed a
stronger correlation between GS and GC than the control group
(ASD: r = 0.22; control: r = 0.002; z = 2.48; see Fig 2Dii–Fii). Thus,
as a gene becomes more highly connected within the cell adhesion
module, it becomes more relevant to brain size in ASD than in the
control group. Along with the evidence showing generalized atypi-
cality in GS in ASD (i.e., reductions in GS in cell cycle and protein
folding modules, but increase in cell adhesion; Appendix Fig S8),
this evidence supports the idea that GS is accompanied by a modest
alteration in GC between groups, indicating that a gene’s relevance
to brain size covaries with changes in network organization in ASD
(Fig 2Dii–Fii). With regard to the cell cycle network in particular,
this network re-organization in ASD can be described as many high
GC genes (i.e., hub-genes located more centrally within the
network) with a reduced GS, but also many low GC genes (i.e.
low-connectivity genes located around the periphery of the network)
which displayed some of the highest GS levels (Fig 2Dii–Fii).
Of the three modules, the cell cycle module displayed the most
severe network re-organization. This can be shown through further
analyses of the top 30 genes on each metric (GS and GC; see Materi-
als and Methods). First, we ran Venn analyses to determine the
gene overlap between ASD and control toddlers and found that the
majority of the genes with highest GS were unique to each group,
especially for the cell cycle gene network with 29 out of 30 genes
being different between groups (Fig 2Diii and Dataset EV1). Then
we investigated whether the top 30 GC genes (i.e., hub-genes) in
the co-expression network were also the top GS genes in each
group. Within the cell cycle module, 16 of the 30 hub-genes also
possessed the top GS scores for controls, while in ASD only 5 of the
30 hub-genes were top GS genes (OR = 5.71, P = 0.004 CI = 1.72–
18.94). The remaining 25 top GS genes in ASD had lower GC
scores, and thus were considered ‘peripheral’ in the cell cycle co-
expression network. While in controls these 25 peripheral genes
displayed a strong positive association between GS and GC
(r = 0.74, P = 2.7e-5), in ASD the directionality of the association
flipped (r = 0.34, P = 0.098; Appendix Fig S9), resulting in a
substantial group difference in correlation strength (z = 4.33,
P = 1.51e-5). For the protein folding module, there were similar
proportions of hub-genes displaying top GS scores in both groups
(OR = 1.96, P = 0.198, CI = 0.70–5.48). However, among the
peripheral genes (i.e. top GS genes with low GC scores), again there
was a flip in directionality of GS-GC correlation (controls r = 0.89,
P = 1.8-e-6; ASD r = 0.19, P = 0.45; z = 0.35, P = 8.60e-8;
Appendix Fig S9). Likewise, the cell adhesion module also
displayed similar proportions of hub-genes with top GS scores
(OR = 1, P = 1, CI = 0.30–3.30). Peripheral genes (i.e., top GS
genes with low GC scores) display similar GS-GC correlations across
controls and ASD (controls r = 0.04, P = 0.85; ASD r = 0.35,
P = 0.094; z = 1.34, P = 0.17 Appendix Fig S9).
This evidence reinforced the findings of network re-organization
and revealed a trend in gene expression relevance for brain size that
shifts from central genes (hub-genes) in control toddlers to periph-
eral genes in ASD toddlers particularly within the cell cycle network.
The overall network perturbation may underlie potential down-
stream consequences in overall transcriptional regulation.
Cell cycle module is preserved and highly expressed during early
stages of normal fetal brain development
We next reasoned that if correct neurodevelopment relies on the
tight modulation of gene networks driving brain size, changes in
expression levels of these networks would likely be most damaging
at early developmental stages. It is also expected that biological
processes involved in cell proliferation (e.g., during the neuronal
progenitor pool expansion) would be expressed at high levels at
earliest ages and lowest during postnatal life when the brain struc-
tures have already been formed.
Based on these hypotheses, we utilized gene expression data
from the Allen Institute BrainSpan Atlas (Miller et al, 2014), in
which control human brain tissues were expression-profiled at
multiple time points from early prenatal stages to adulthood. First,
we examined which of the modules detected in blood would be
highly preserved in a WGCNA on BrainSpan data. Several of the 22
ª 2015 The Authors Molecular Systems Biology 11: 841 | 2015
Tiziano Pramparo et al Converging evidence in autism point to cell cycle networks Molecular Systems Biology
5
blood-modules were moderately to highly preserved (i.e., moder-
ate = Zsummary values between 2 and 10; high = Zsummary > 10;
Fig 3A; see statistics in Appendix Table S5). The cell cycle module
(greenyellow) showed the highest level of preservation (e.g., Zsum-
mary = 14 and top median rank), suggesting that its network struc-
ture is highly preserved in human brain samples taken at different
developmental stages. Due to its relevance for development, we
next focused on the cell cycle module and investigated the develop-
mental trajectory of the gene expression and specifically tested the
hypothesis that expression would be upregulated in prenatal vs
postnatal time points. Indeed, BrainSpan cell cycle ME values from
prenatal time points were much higher than at postnatal time points
(Wilcoxon rank sum z = 3.51, P = 4.44e-4; Fig 3B and C). Of note,
consistent with prior literature indicating that cell cycle processes
are important to drive early brain development, our findings provide
postnatal in vivo evidence of gene expression alterations in ASD that
can be traced back to early developmental stages and that are rele-
vant to brain size.
Network perturbation is more pronounced in bigger ASD brains
We next wanted to test whether the cell cycle module showed high
levels of protein–protein interactions (PPIs) and how perturbation
of these PPI genes would be relevant to brain size variation in ASD.
This analysis would also provide independent validation that gene
products (proteins) within the same biological process, such as cell
cycle, display consistent perturbations; we have detected from the
co-expression analysis. In addition, we designed the PPI analysis to
determine whether smaller brains significantly differed from bigger
brains in ASD compared to controls.
A
B C
Figure 3. BrainSpan preservation analysis and cell cycle developmental trajectory.
A Preservation analysis between BrainSpan dorsolateral prefrontal cortex gene expression data and the ASD + control blood data. Zsummary statistic (e.g.,
Zsummary > 10 means highly preserved, Zsummary in between 2 and 10 is weak to moderate preservation, Zsummary < 2 is little to no preservation and median
rank (modules with lowest rank are highly preserved)). Median Rank and Zsummary values indicate high module preservation between the two datasets.
B Boxplot showing module eigengene (ME) values the BrainSpan cell cycle module for fetal versus postnatal time points (15 fetal versus 16 postnatal time points). The
box refers to the interquartile range (IQR), which we refer to as Q1 (25th percentile) and Q3 (75th percentile). The upper whisker represents Q3 + 1.5*IQR, while the
lower whisker represents Q1  1.5*IQR. The line in the middle of the box represents the median.
C Scatterplot indicating the BrainSpan cell cycle module trajectory across development (vertical line indicates birth; time points to the left of the line are fetal time
points, while time points to the right of the line are postnatal time points; best-fit curve indicates a 4th order polynomial fit).
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A cell cycle reference network based on PPI was constructed by
querying all 253 genes from the cell cycle module using the DAPPLE
database (Rossin et al, 2011). Out of these genes, 119 displayed
a higher number of PPIs compared to chance (P < 0.001;
Appendix Fig S10; see PPI stats in Dataset EV1). We then mapped
onto this reference PPI network the top 30 hub-genes relevant to
brain size that we previously identified in the combined co-expression
network analysis (Fig 2Diii–Fiii). Of the top 30 hub-genes, 19
and 20 genes (in control and ASD, respectively) mapped into the
PPI network (Dataset EV1). For each of these, 19 and 20 hub-genes
in the PPI network, we re-calculated their GS scores and P-values
(see Materials and Methods) for subgroups with either smaller (GS-
SM, residuals < 0 cc) or bigger (GS-BG, residuals > 0 cc) than the
mean average brain size (see Fig 2A) and compared their GS scores
with the GS scores calculated from the previous combined analysis
using all brains (GS-ALL). We used the lowest GS-ALL value as
threshold in each group and observed whether the new GS-SM or
GS-BG values passed this GS-ALL threshold. When a gene did not
meet the GS-ALL threshold in GS-SM or GS-BG subgroups, we
considered the gene as losing its relevance to brain size within the
subgroup. If a gene passed the GS-ALL threshold in GS-SM or GS-BG
subgroups, we considered that gene as retaining or gaining rele-
vance within the subgroup.
Surprisingly in controls, all 19 genes passed the GS-ALL thresh-
old in both the small and big brain subgroups (Fig 4A and
Dataset EV1). This suggested that brain growth in control toddlers
is possibly driven by a common set of genes regardless of size varia-
tion. In ASD, 14 of these 19 genes passed the GS-ALL threshold in
A B C
Figure 4. Topological analysis of cell cycle hub-genes in a protein–protein interaction (PPI) network.
Mapping of the top 30 hub-genes relevant to TBV measures in smaller and bigger ASD and control brains.
A Hub-genes that are normally active in control toddlers.
B Hub-genes that are active in both control and ASD toddlers.
C Hub-genes that are abnormally active in ASD toddlers.
Data information: Node size (circle) is proportional to the number of actual biologically driven PPIs. Blue and red nodes are hub-genes that displayed PPIs and were in
the top 30 lists in control and ASD, respectively. Grey nodes are genes in the cell cycle PPIs network that were not ranked within the top 30 genes. Black nodes are genes
that fall out from the top 30-gene list in ASD compared to control.
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the small brain subgroup (Fig 4B and Dataset EV1). The difference
in these ratios (i.e. 19/19 in controls vs 14/19 in ASD) was signifi-
cant (OR = 14.8, P = 0.02, CI = 0.75–289.4). Conversely, in ASD
only 1 gene (CCNB2) passed the GS-ALL threshold in the big brain
subgroup (Fig 4B) and this difference in ratios (i.e. 19/19 in controls
vs 1/19 in ASD) was highly significant (OR = 481, P = 3.35e-9, CI =
18.4–12,570). Lastly, we identified the genes that were unique to
smaller or bigger ASD brains, thus either lost or gained relevance for
size. A total of 9 hub-genes were found abnormally correlated
(ZWINT, CENPE, MCM10, and UHRF1), or uncorrelated (CDC20,
BUB1, NEK2, PTTG1, and CCNE2) with smaller ASD brains. Bigger
ASD brains instead displayed greater PPI network alteration in
respect to smaller brains with 18 genes (Fig 4C and Dataset EV1)
losing correlation strength for size, while 1 gene (UBE2C) displayed a
gain in correlation for bigger brains (14 and 9 in smaller vs 1 and 18
in bigger ASD brains; OR = 28, P = 2.2-e-4, CI = 3.2–248; Fig 4C).
In total, we identified 23 co-expressed hub-genes within the cell
cycle PPI network abnormally related to brain size variation in ASD
that are good candidate genes for brain maldevelopment (Dataset
EV1). These findings added substantial biological validation to the
above genetic interaction analyses that showed genes governing
brain size in ASD and controls are substantially different from each
other. Furthermore, while such differences are present for both
smaller and bigger ASD brains, the difference from controls is much
greater for bigger ASD brains compared to smaller ASD brains.
Cell cycle networks link gene expression dysregulation, mutation
and brain maldevelopment
A large body of evidence suggests that developmental alteration of
genes that control cell number may underlie neuropathology of ASD
(Courchesne et al, 2001, 2007, 2011b). Moreover, recent genomic
studies identified High-confidence (Hc) genes with loss-of-function
mutations that are involved in large networks including functions in
the regulation of cortical cell number production (Willsey et al,
2013; De Rubeis et al, 2014). Two Hc genes were also found
mutated in subjects with significantly smaller (DYRK1A) and bigger
(CHD8) heads (O’Roak et al, 2012).
To identify specific molecular mechanisms of dysregulation, we
tested the hypothesis that these Hc genes may be at least partially
involved in the upstream regulation of the 23 PPI candidate genes
we identified abnormally expressed in ASD. Thus, we constructed
an Hc network by using 32 Hc genes (out of the 33 reported in De
Rubeis et al, 2014) in Metacore GeneGO to identify their direct
downstream targets. These Hc genes are associated with pleiotropic
roles including not only the regulation of synaptic processes, but
also the regulation of cell number and expression of other down-
stream genes (Dataset EV1) (Geschwind & State, 2015). The Hc
network included a total of 414 genes (Fig 5). Similarly, we queried
the same database to obtain the list of genes with regulatory
functions upstream of the 23 PPI candidate genes and mapped these
genes in the Hc network. One hundred and six (106) genes were
identified as upstream regulatory. A schematic description of the
network construction can be found in Fig EV1.
Analysis of the integrated Hc network demonstrated that four of
the 23 PPI candidate genes (AURKA, CDK1, CCNA2 and CCNE) were
direct downstream targets of Hc genes (CHD8, ARID1A/B, and CUL3)
and upstream regulators of other PPI candidate genes (Fig 5). Using
differentially expressed (DE) from a companion study (Pramparo
et al, 2015), we found that eight Hc genes (CHD8, ARID1A, ASH2L,
ACTB, NR3C2, SUV420H1, ADPN, and MYO9B) were DE in leuko-
cytes obtained from ASD and control (Fig 5). Four other Hc genes
(CUL3, SYNGAP1, NAA15, and ARID1B) were upstream regulators of
the PPI candidate genes and CUL3, SYNGAP1, and NAA15 were also
DE in postmortem brain tissue (Voineagu et al, 2011; Pramparo
et al, 2015; Fig 5). Several other upstream regulatory genes were
included in the Hc network, such as E2F1, MYC, GSK3, YWHAB,
ESR1, EGFR, PCNA, CDKN1, and ERBB1. Most importantly, many key
upstream regulatory genes were DE in leukocytes, such as CHD8,
ARID1A, AKT1, Beta-catenin (CTNNB1), SMAD3, CREB1, and
NOTCH1 and/or in postmortem brain tissue (TCF4, CREB1, SMAD3,
CAMK2A, LIMK1, NCOA3, CCNE1, and BRD2).
We found an over-representation of DE genes, previously identi-
fied in (Pramparo et al, 2015), among the upstream regulatory
genes (n = 106) in the Hc network (n = 414) (see Materials and
Methods; Hyp. P = 1.e-12), suggesting their role in regulating the
cell cycle network. Further pathway analysis of the upstream regula-
tory genes displayed a strong enrichment in processes involved in
the regulation of cell cycle phase transition (G2-M and G1-S) under
the master regulation of APC (inducing progression and exit from
mitosis), ESR1 (promoting G1-S transition) and ATM (initiating
G2-M arrest) genes (Dataset EV1). Top signal transduction
pathways were PTEN (P = 2e-16, FDR = 4e-14), ESR1 (P = 5.7e-14,
FDR = 2.1e-12) and NOTCH (P = 2.2e-13, FDR = 4.4e-12). These
findings demonstrate a clear connection between the dysregulation
of cell cycle gene networks and abnormal brain size/development
in ASD toddlers. Overall, a large proportion of genes in the Hc
network were DE in postmortem brain tissue (Hyp. P = 2.6e-11),
demonstrating the validity and relevance of the Hc network in brain
tissue development and function. Lastly, a significant enrichment
was found also for SFARI ASD candidate genes (excluding the 32 Hc
query genes; 706 curated SFARI genes Updated March, 2015) within
the Hc network (Hyp. P = 1.4e-13), further reinforcing the link of
the cell cycle network to ASD.
CHD8-subnetwork perturbation causes significant loss of
association with brain size in ASD via E2F-dependent genes
expressed at G1-S phase transition
We further analyzed the Hc network to pinpoint which of the Hc
subnetworks displayed gene expression levels associated with
normal brain size and whether the dysregulation of gene expression
in ASD would significantly disrupt this association with ASD brains
(see Materials and Methods). Hc subnetworks were defined based
on each Hc gene as central hub and all the genes that directly linked
to it. We then extracted expression values from our dataset for all
genes in each Hc subnetwork and calculated the average expression
value for each subnetwork. For instance, CHD8 was directly linked
to a total of 25 genes (Fig 6A) and 16 had expression values; thus,
the average expression for the CHD8 subnetwork was calculated
using these 16 genes. Next, we ran linear correlations between each
average subnetwork expression value and TBV measures and tested
whether the strength of these correlations significantly differed
between ASD and control groups. Out of all the Hc subnetworks,
three were found with significant associations (CHD8, NR3C2,
APH1A), and only the CHD8 subnetwork displayed significant group
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differences via permutation analysis (see Appendix Table S6,
Fig 6B). The significant association of the CHD8 subnetwork in
controls was found to be independent of age by linear modeling and
ANOVA testing (see Appendix Table S7).
This evidence suggested an important role of CHD8 on brain size
in ASD which is strongly supported by a growing literature describ-
ing its mutations (O’Roak et al, 2012; Bernier et al, 2014; McCarthy
et al, 2014; Prontera et al, 2014) and function (Rodriguez-Paredes
et al, 2009; Subtil-Rodriguez et al, 2014; Sugathan et al, 2014).
Recent in vitro studies aiming to define the cellular phenotypes
and downstream targets of CHD8 supported the relevance of this
subnetwork to brain size. Indeed, five brain-relevant genes included
in the CHD8-subnetwork (CCNE2, TYMS, CCNA2, CDC6, and BRCA2)
were reported with impaired expression upon CHD8 knockdown
(Rodriguez-Paredes et al, 2009; Subtil-Rodriguez et al, 2014). Dysreg-
ulation was found specific for E2F-dependent genes expressed during
G1-S phase transition in proliferating cells, supporting our findings
that point to this mechanism as underlying brain maldevelopment in
ASD (Subtil-Rodriguez et al, 2014). To test whether potential down-
stream effects of CHD8 would converge to the same gene networks
we found dysregulated in ASD, we ran pathway analysis using the
CHD8-targets identified by ChIP-chip in two independent studies
(Sugathan et al, 2014; Cotney et al, 2015). Most importantly, we ran
enrichment on the common targets from these studies. Analysis of
the common genes found DE and CHD8 bound in neuronal progeni-
tor cells (NPCs) from the Sugathan study (Sugathan et al, 2014)
showed enrichment in development, signaling processes, and tran-
scription as well as DNA-damage and cell cycle functions (Dataset
Figure 5. High-confidence (Hc) network.
A Hc network was generated following the approach represented in Fig EV1. Big nodes represent Hc genes (grey or colored circles). Small grey or colored circles represent
direct downstream targets of the Hc genes. Colors code for different categories of genes mapped into the Hc network. Red indicates genes that are differentially expressed
(DE) in blood of the same subjects described in this study. Cyan indicates genes that are upstream and regulate any of the 23 brain-relevant genes identified in this
study. Green indicates genes that are both DE and regulators of the 23 brain-relevant genes. Big cyan diamond shapes are brain-relevant genes that mapped into the Hc
network. Bold circle outlines represent genes that are DE in postmortem brain tissue of ASD donors.
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EV1). Common targets from Sugathan et al and Cotney et al (hNSC
and brain genes, N = 1,620 and N = 1,662, respectively) studies
showed a strong enrichment for cell cycle and DNA-damage
processes with prominent S phase functions (Fig 6C). Of note, we
looked for enrichment in perturbed cell cycle genes that we identified
(greenyellow module) using the common targets from Sugathan et al
and Cotney et al (hNSC and brain genes) and we found significant
enrichment when using the hNSC genes (Hyp. P = 6.3e-5).
Altogether, these data suggest a role for CHD8 in development.
Upon disruption, its downstream effects converge to genes and
networks we have found predicting risk for ASD, associated with
brain maldevelopment in ASD and pointing to mechanisms that
affect regulation of cell phase transition during mitotic cycle via
E2F-dependent genes.
Discussion
This study of in vivo gene expression relationships with early brain
size addresses questions relevant to ASD patho-etiology and
physiology. It is currently unknown whether blood gene expression
can be used to identify biomarkers of brain maldevelopment in vivo
at early ages and/or whether these biomarkers could elucidate the
molecular mechanisms underlying fetal cortical maldevelopment.
Several lines of evidence suggest that aberrant regulation of cell
number may underlie the ASD neuropathology during the second/
third trimester of prenatal life. However, fundamental limitations,
related to the inaccessibility of the tissue in vivo and the paucity of
young postmortem samples, prevent the testing of this hypothesis
with both exploratory and targeted research. Our study represents a
step in this direction and aims to lay the groundwork for further
hypothesis-driven investigations. A systems-level analysis of biolog-
ical networks is indeed required to build a framework to understand
the spatio-temporal scale, the effects of perturbation and the result-
ing physiological states characterizing diseases (Ge et al, 2003;
Somvanshi & Venkatesh, 2014). Thus, our findings suggest a point
of reference to further the study of alterations in genes and biologi-
cal processes that underlie neuropathology of ASD.
Here, we identified gene networks—cell cycle and protein folding
—in blood that strongly correlate with early brain size in control
A
C
B
Figure 6. CHD8 subnetwork analysis in relationship to brain size and downstream CHD8-knockdown effects in vitro.
A CHD8 subnetwork analysis included all CHD8-targets from the Hc network. Network legend is the same as in Fig 5: grey (downstream CHD8 target), cyan (upstream
regulatory gene of brain-size relevant genes altered in ASD), red (differentially expressed in blood), green (cyan and red), diamond shape (brain-size relevant gene
altered in ASD), and black circle (differentially expressed in ASD cortex from Voineagu et al, 2011).
B Linear correlation analysis of gene expression levels with TBV measures in ASD and control toddlers. See permutation analysis in Appendix Table S6. **P < 0.001.
C Pathway analysis in Metacore. FDR < 0.05.
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toddlers. We additionally identified dysregulated gene networks in
blood that correlate with early brain maldevelopment in infants and
toddlers with ASD. These gene networks retained functional enrich-
ment in human brain tissue and displayed consistent expression
profiles during cortical fetal development.
The combined findings of this study suggest that there is a prena-
tal disruption of neuron number regulation, cell differentiation, and
overall architecture of the developing cortex in ASD. Underlying this
disruption is an abnormal functional organization of cell cycle and
protein folding gene networks and the abnormal activation of other
functional networks, such as cell adhesion. Thus, our evidence
suggests that brain maldevelopment in autistic infants involves
dysfunction in such gene networks.
The present evidence of abnormal cell cycle networks involved
in early brain maldevelopment in ASD is consistent within a larger
and well-established animal model literature that cell cycle molecu-
lar machinery governs the overall size of the brain (Nakayama et al,
1996; Groszer et al, 2001; Chenn & Walsh, 2002; Ferguson et al,
2002; Feng & Walsh, 2004; Dehay & Kennedy, 2007; Ellegood et al,
2014) and supports the original theory proposed to explain early
brain overgrowth in ASD (Courchesne et al, 2001). Here, we used
the cell cycle network in leukocytes as an entry point to dissect the
transcriptional alterations underlying pathology in living ASD
infants and toddlers across developmental brain sizes, from small to
abnormally large. Cell cycle network abnormalities involved
substantial alteration of activity patterns of cell cycle hub-genes and
modulation in expression of different peripheral genes. Such func-
tional abnormality in the cell cycle network was greatest in ASD
infants and toddlers who had bigger brain size, and moderate in
those who had smaller brain size.
Abundant research shows that, beyond its effects on global brain
and cerebral cortical size, cell cycle dysregulation can impact the
core foundational framework of the fetal brain. Disruption may
involve area-specific rates of cell production, cortical areal expan-
sion, cell-fate determination, cell migration and differentiation, lami-
nar specification, DNA integrity, the genesis of the connectivity of
critical transient structures (subplate), and the generation of cyto-
architectonic maps (Galderisi et al, 2003; Dehay & Kennedy, 2007).
Thus, we hypothesize disruptions in cell cycle regulation in early
prenatal life may be a key defect underlying ASD. Such disruption
may explain why some cortical regions have excess cells
(Courchesne et al, 2011b) while other regions have too few (van
Kooten et al, 2008). It may also explain why there are focal patches
of disorganized prefrontal and temporal cortex in which cell-type
and laminar-specific ISH expression are abnormally reduced (Stoner
et al, 2014); this cortical pathology points to failure of the full
normal cell- and laminar-fate program, which should be completed
during the second and third trimesters (Stoner et al, 2014). More
broadly, because the cell cycle disruption we identified appears to
vary across affected ASD individuals with greater disruption associ-
ated with brain enlargement and lesser with smaller brain size, varia-
tion in the timing, nature and cellular location of its disruption could
explain some aspects of variation in brain microstructural and func-
tional outcome as well as clinical symptom heterogeneity in ASD.
Using a reverse genetic approach, we demonstrated that brain
maldevelopment in ASD is likely due to the disruption of cell cycle
networks, which in turn is related to key genes that have been
frequently found mutated in ASD (De Rubeis et al, 2014). For the
majority of high-risk ASD genes, the specific functional role and
modalities of interactions are currently unclear. A recent literature
review focusing on regulatory roles for genes in neurogenesis,
neural induction, and neuroblast differentiation found that the vast
majority of high-risk ASD genes help to regulate neural induction
and early neuroblast development (Casanova & Casanova, 2014).
Most importantly, the majority of core set genes influence neuronal
development through multiple stages and are not limited to one
single process. This pleiotropy of functions likely suggests that dif-
ferent modalities of interaction may co-exist, such as DNA-, RNA-,
and protein-binding and may vary depending upon cell type and
stage of development. The integrated Hc network displays a high
content of regulatory elements strongly enriched in cell cycle phase-
transition functions, suggesting that cell cycle length and timing
may be one possible disrupted mechanism that can, at least
partially, explain the downstream alteration of hub-genes associated
with brain maldevelopment in ASD. This hypothesis is consistent
with recent findings describing alterations of cell cycle timing and
excess cell proliferation of neuroprogenitor cells derived from
fibroblasts of living ASD patients who displayed early brain over-
growth (Marchetto et al, unpublished data). Several genes in the Hc
network (e.g. E2F1, Cyclins, MYC, CHD8, PIK3, AKT1, GSK3, PCNA,
ERBB2, Beta-catenin, and SMAD3) are known to play a role in G1/S
and G2/M checkpoints, and to regulate neurogenesis (Zhu et al,
2003; Zhou & Luo, 2013). Some of these genes are also dysregulated
in dorsolateral pre-frontal cortex of young ASD cases (e.g. GSK3,
AKT1, Beta-catenin, CREB1, SP1, TP53, SRC, FPS, and NODAL;
Voineagu et al, 2011; Chow et al, 2012). At the pathway level,
PTEN, NOTCH and ESR transduction signals point to the same cell
cycle phase-transition dysregulation. PTEN is a well-known tumor
suppressor gene that counteracts the activation of PIK3/AKT in
proliferation/self-renewal of neural progenitor cells, both in vivo
and in vitro (Worby & Dixon, 2014). In vivo, its ablation leads to
enhanced self-renewal capacity, accelerated G0-G1 cell cycle entry
(Groszer et al, 2001, 2006; Gregorian et al, 2009), and faster transi-
tion from the G2/M to the G1 phase in embryonic stem cells result-
ing in overall shortened cell cycle (Kandel et al, 2002). Importantly,
PTEN mutations have been found associated with enlarged brain
size in ASD subjects (O’Roak et al, 2012) and one ASD PTEN brain
has > 100% excess prefrontal neurons (Courchesne et al, 2011b;
Courchesne personal communication). A target of PTEN signaling is
the NOTCH pathway that as well represents a key regulator of
neural stem cells (NSCs) maintenance. NOTCH inhibition has been
shown to delay G1/S phase transition and commit NSCs to neuroge-
nesis (Borghese et al, 2010). Similarly, the ESR1 pathway acts like a
ligand-dependent transcription factor and promotes G1/S transition
through several pathways (Prall et al, 1997; Foster et al, 2001).
Lastly, in addition to cell cycle dysfunction, we also found
dysregulation of cell adhesion and protein folding networks in ASD
toddlers. Alteration of cell adhesion functions, as in our case
mediated by integrins, may have pleiotropic effects during both
early and later developmental stages. During early cortical develop-
ment neurogenesis, neuronal migration and cell specification are
most active (Schmid & Anton, 2003), while later in development
synapse formation, finalization and function become of primary
importance (Milner & Campbell, 2002). Converging evidence shows
that accumulation of misfolded proteins leads to the Unfolded
Protein Response (UPR) (Walter & Ron, 2011) which in turn may
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underlie impaired synaptic function in ASD (Fujita et al, 2010;
Falivelli et al, 2012), as well as global alterations of transcriptional
regulation (Mendillo et al, 2012). Analysis of CHD8 knockdown
in vitro has provided evidence converging its downstream effects
on transcriptional regulation to pathways we found altered in ASD
(translation, cell cycle, protein folding, and cell adhesion).
Figure 7. Schematic representations of mechanisms that may underlie brain maldevelopment in ASD.
In control brains (top panel), both smaller and bigger brains develop and function normally. At the cellular level, there are no significant alterations of cell division phases and
the number of cells produced is within normal variation. At the molecular level, there are no genetic alterations and changes in gene expression are within normal
variation with no significant alterations of network structure and function. In ASD brains (bottom panel), brain development is abnormal and smaller and bigger brains
represent two different anatomical and functional outcomes. In smaller ASD brains, the cellular characteristics are currently less clear compared to bigger brains. We
hypothesize that G1/S phase transitions may be longer and/or checkpoints may stall/delay the timing of cell divisions leading to a reduced number of cells. Alternatively, there
are an increased number of apoptotic cells. These cellular phenotypes may be related to genetic mutations (red lightning bolt) of Hc genes that, for instance, regulate
chromatin modification as in case of CHD8 (blue). The mutation leads to altered regulation (red arrows) of downstream transcription factors or regulatory elements (yellow,
cyan, green diamond shapes) that in turn regulate the expression of brain-relevant genes (purple square). Mutated CHD8 can also alter directly the expression of
brain-relevant genes, as in case of CCNE2. Gene expression and network functions are altered, but closer to normal brains. In bigger brains, cellular andmolecular phenotypes
are more pronounced compared to smaller ASD brains. Cellular evidence suggests that the increased number of neurons may be due to the shortening of G1/S phases. At the
molecular level, this may be related to mutations and changes in gene expression that lead to a reorganization of networks controlling neuroprogenitor cell divisions. In
addition to the downstream effects of Hc mutations (i.e. CHD8, red arrows), pronounced gene expression changes cause a substantial reorganization of the network with the
activation of new regulatory genes (i.e., TOP2A, TYMS, triangle shapes) and new interactions (green arrows), thus leading to altered or different network functions.
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Conclusion
Our study provides compelling evidence to demonstrate that analy-
ses of gene expression in peripheral blood allow the identification
of functional genetic correlates of brain maldevelopment in ASD.
Results point to convergent pathways of altered expression of
genes and networks that ultimately lead to abnormal regulation of
neuron production via defective G1/S phase transition during early
stages of brain development (Fig 7), thus likely affecting neuropro-
genitor divisions. While larger ASD brains display greater networks
alterations with shorter G1/S phase timing (Marchetto et al,
unpublished data) (Fig 7), the molecular underpinning of smaller
brains remains less clear. It is plausible to hypothesize that either
a lengthening of the G1/S phases or a checkpoint delay/malfunc-
tion may lead to reduced number of neurons or to increased cell
removal (Fig 7).
Together with previous evidence (Courchesne et al, 2011b;
Chow et al, 2012; Parikshak et al, 2013; Willsey et al, 2013; Stoner
et al, 2014), we argue that disruption of gene networks related to
specific prenatal genetic programs may underlie abnormal neuronal
development in both small and large brains and may be part of the
cause of ASD in a majority of individuals. Furthermore, genetic
programs that control synapse development in early life provide a
core functional neuronal component essential to further brain
development and complex process elaboration; genetic defects in
such genes have long been theorized, but not demonstrated, to
impact postnatal brain growth and function in ASD (Parikshak
et al, 2013). Further elucidation of these functional genomic
pathologies underlying early brain development in ASD will facili-
tate research into biological targets for biotherapeutic intervention
and development of accurate biomarkers for the early detection of
babies and infants at risk for ASD.
Materials and Methods
Subject recruitment, tracking, and developmental evaluation
Research procedures were approved by the Institutional Review
Board of the University of California, San Diego (No. 110049). Infor-
mation on subject recruitment, evaluation, RNA samples, and gene
expression procedures are provided also in a recent companion
study (Pramparo et al, 2015). Toddlers were recruited via the 1-Year
Well-Baby Check-Up Approach from community pediatric clinics
(Pierce et al, 2011) as well as via referral from other community
sources and evaluated using a battery of standardized and experi-
mental tests that included: the Autism Diagnostic Observation
Schedule (ADOS; Lord et al, 2000; Luyster et al, 2009), the Mullen
Scales of Early Learning (Mullen, 1995) and the Vineland Adaptive
Behavior Scales (Sparrow et al, 2005). Diagnoses were determined
via these assessments and the Diagnostic and Statistical Manual,
Fourth Edition (DSM IV-TR) (American Psychiatric Association,
2000). Testing sessions generally lasted 4 h and occurred across 2
separate days and the blood sample was usually taken at the end of
the first day. Parents were interviewed with the Vineland Adaptive
Behavior Scales (Sparrow et al, 2005) and a medical history inter-
view. All toddlers were developmentally evaluated by a Ph.D. level
psychologist and those that were younger than 3 years at the time
of blood draw were tracked every 6 months until their 3rd birthday
when a final diagnosis was given. Only toddlers with a provisional
or confirmed ASD diagnosis were included in this study. Our recent
study (Pierce et al, 2011), which included the participation of 137
pediatricians who implemented > 10,000 CSBS screens showed that
75% of toddlers that fail the screen at the 1st year exam have a true
delay (either ASD, language delay, global developmental delay or
other condition). While ASD toddlers were as young as 12 months
at the time of blood sampling, all but 3 toddlers have been tracked
and diagnosed using the ADOS toddler module (Luyster et al) until
at least age two years, an age where diagnosis of ASD is relatively
stable (Cox et al, 1999; Kleinman et al, 2008; Chawarska et al,
2009). Toddlers received the ADOS module that was most appropri-
ate for their age and intellectual capacity. Of the 87 enrolled ASD
subjects, 64% had an ADOST, 31% had an ADOS 1, and 5% had an
ADOS 2. Only toddlers with a provisional or confirmed ASD diagno-
sis were included in this study. Twenty-four final diagnoses for
participants older than 30 months were also confirmed with the
Autism Diagnostic Interview–Revised (Luyster et al). In order to
monitor health status, the temperature of each toddler was taken
using an ear digital thermometer immediately preceding the blood
draw. If temperature was higher than 99, then the blood draw was
rescheduled for a different day. Parents were also asked questions
regarding their child’s health status such as the presence of a cold
or flu, and if any illnesses were present or suspected, the blood
draw was rescheduled for a different day. The control group was
comprised of typically developing toddlers as well as contrast
toddlers (Table 1).
RNA extraction, quality control and samples preparation
Four to six milliliters of blood was collected into EDTA-coated tubes
from toddlers on visits when they had no fever, cold, flu, infections
or other illnesses, or use of medications for illnesses 72 h prior blood
draw. Blood samples were passed over a LeukoLOCKTM filter
(Ambion, Austin, TX, USA) to capture and stabilize leukocytes and
immediately placed in a 20°C freezer. Total RNA was extracted
following standard procedures and manufacturer’s instructions
(Ambion, Austin, TX, USA). LeukoLOCK disks were freed from
RNA-later and Tri-reagent was used to flush out the captured
lymphocyte and lyse the cells. RNA was subsequently precipitated
with ethanol and purified though washing and cartridge-based steps.
The quality of mRNA samples was quantified by the RNA Integrity
Number (RIN), values of 7.0 or greater were considered acceptable
(Schroeder et al, 2006), and all processed RNA samples passed
RIN quality control. Quantification of RNA was performed using
Nanodrop (Thermo Scientific, Wilmington, DE, USA). Samples were
prep in 96-well plates at the concentration of 25 ng/ll.
Gene expression and data processing
RNA was assayed at Scripps Genomic Medicine (La Jolla, CA, USA)
for labeling, hybridization, and scanning using expression
BeadChips pipeline (Illumina, San Diego, CA, USA) per the
manufacturer’s instruction. All arrays were scanned with the Illu-
mina BeadArray Reader and read into Illumina GenomeStudio
software (version 1.1.1). Raw data was exported from Illumina
GenomeStudio, and data pre-processing was performed using
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the lumi package (Du et al, 2008) for R (http://www.R-project.org)
and Bioconductor (http://www.bioconductor.org; Gentleman et al,
2004).
Several quality criteria were used to exclude low-quality arrays as
previously described (Chow et al, 2011, 2012). In brief, low-quality
arrays were those with poor signal intensity (raw intensity box plots
and average signal > 2 standard deviations below the mean), deviant
pairwise correlation plots, deviant cumulative distribution function
plots, deviant multi-dimensional scaling plots, or poor hierarchical
clustering (Oldham et al, 2008). Five samples (four ASD and one
control) were identified as low quality due to poor detection rates,
different distributions, and curved dot plots, and were removed prior
normalization. Eighteen (18) samples had 1 replicate and all
pairwise plots of each replica had a correlation coefficient of 0.99.
Hierarchical clustering of these replicated samples showed 13
samples having with the two replicas that clustered together; there-
fore, the B array was arbitrarily chosen for the following steps. For
the remaining 5 of these replicated samples, the two replicas did not
cluster together; thus, the averaged gene expression levels were used
in the following steps. No batch effects were identified. BrB-array
filtering Tool was used to obtain a final set of genes without missing
expression values. Filtering criteria were Log Intensity Variation
(P > 0.05) and percent missing (> 50% of subjects). A total of 142
final samples/arrays (87 ASD, 55 control), and thus 142 unique
subject datasets, were deemed high quality and entered the expres-
sion analysis. Inter-array correlation (IAC) was 0.983. From among
these subjects, 65 ASD and 38 controls had parental consent for
MRI testing and neuroanatomical analysis.
MRI scanning and neuroanatomic measurement
Scanning was performed with a 1.5 T GE scanner. A T1-weighted
IR-FSPGR sagittal protocol (TE = 2.8 ms, TR = 6.5 ms, flip angle =
12 deg, bandwidth = 31.25 kHz, FOV = 24X cm, slice thickness =
1.2 mm, 165 images) was collected during natural sleep(Eyler et al,
2012). FSL’s linear registration tool (FLIRT) rigidly registered brain
images to a custom template that was previously registered into
MNI space (Jenkinson & Smith, 2001). Registered images were then
processed through FSL’s brain extraction tool (BET) removing skull
and non-brain tissue (Smith, 2002). Remaining non-brain tissue was
removed by an anatomist to ensure accurate surface measurement.
Gray matter, white matter, and CSF were segmented via a modified
version of the FAST algorithm (Zhang et al, 2001) using partial
volumes rather than neighboring voxels to increase sensitivity for
detecting thin white matter in the developing brain (Altaye et al,
2008). The brain was divided into cerebral hemispheres, cerebellar
hemispheres, and brainstem via Adaptive Disconnection (Zhao
et al, 2010). Each cerebral hemisphere mask was subtracted from a
sulcal mask generated by BrainVisa and recombined with the
original FSL segmentation to remove all sulcal CSF voxels. The
final hemisphere mask was reconstructed into a smoothed, three-
dimensional mesh in BrainVisa to obtain surface measures (Rivie`re
et al, 2009). ASD neuropathology exhibits larger brain size in a
substantial proportion of affected toddlers (Courchesne et al, 2007,
2011a). In order to overcome trivial effects due to brain size
differences between ASD and control toddlers, we randomly
equilibrated the control sample with large-brain subjects. Total
brain volume (TBV) measures were age-corrected using a general-
ized additive model (GAM-R package v1.06.2; Hastie & Tibshirani,
1995).
A semi-automated pipeline integrating features of FSL (www.
fmrib.ox.ac.uk/fsl/) and BrainVisa (brainvisa.info) provided total
brain volume (TBV). TBV measures were age-corrected using a
generalized additive model (GAM-R package v1.06.2) (Hastie &
Tibshirani, 1995).
Weighted gene network co-expression and preservation analyses
Weighted gene network co-expression analysis (WGCNA) was used
to identify gene modules across all 142 subjects and to calculate the
first principal component of each module, herein called module
eigengene (ME). All subjects were used in WGCNA to represent the
largest gene expression variance available in each ME. Co-expression
analysis was run by selecting the lowest power for which the scale-
free topology fit index reached 0.90 and by constructing an unsigned
(i.e., bidirectional) network with a hybrid dynamic branch cutting
method to assign individual genes to modules (Pramparo et al,
2011). To generate random co-expressed modules for statistical
analysis (see below), we scrambled 10,000 times module-color
assignment for each gene and generated random co-expressed
modules with the same number of genes of the real analysis.
Module preservation analysis (Langfelder et al, 2011) was used
to test network structure against random chance in the combined
WGCNA and to test comparability of modules structure between
ASD and control datasets. Module preservation analysis was also
used to compare network structure between the combined dataset
and BrainSpan dataset. We assessed quality measures for the
Table 1. Summary of subject characteristics and clinical information.
Subject characteristics (all male) ASD control
AD 77
PDD-NOS 10
TD 41
Other* 14
Age in years – mean (SD) 2.3 (0.7) 2.7 (0.7)
Mullen scales of early learning (T-scores) – mean (SD)
Visual reception 39.7 (11.0) 53.55 (9.65)
Fine motor 37.3 (12.2) 55.85 (8.75)
Receptive language 29.1 (12.0) 49.65 (98.4)
Expressive language 29.1 (11.4) 50 (8.7)
Early learning composite 71.0 (16.2) 104.6 (11.9)
Autism diagnostic observation schedule (ADOS)† mean (SD)
ADOS CoSo/SA score 15.0 (3.9) 3.1 (2.7)
ADOS RRB score 4.1 (1.9) 0.4 (0.8)
ADOS total score 19.1 (4.7) 3.6 (3.2)
Vineland scores (VABS)‡ 82.2 (9.4) 97 (8.45)
* > Toddlers from “Other” category included language delay (n = 9),
radiological abnormality (n = 1), premature birth but tests within the normal
range on standardized tests (n = 2), socially emotionally delayed (n = 1), and
prenatal drug exposure (n = 1).
†All toddlers received either the Toddler Module or Module 1 or 2, depending
on age and verbal ability at time of testing. Sample: 64% of ASD population
had ADOS T, 31% had ADOS Mod. 1, and 5% had ADOS Mod. 2.
‡Adaptive Behavioral Scales Adaptive Behavior Composite Score.
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Zsummary component with the related log.P-values (log10(P-values))
extracted from the preservation function output. Documentation
for these types of analysis can be found here: http://labs.genetics.ucla.
edu/horvath/CoexpressionNetwork/ModulePreservation/Tutorials/.
Two network metrics available in the WGCNA package were
used to quantify networks perturbation and included: Gene Signifi-
cance (GS) and Gene Connectivity (GC). GS is the correlation
strength of gene expression levels with TBV and represents a
measure of “biological significance or relevance” to a trait
(Langfelder & Horvath, 2008). GC is a measure of correlation among co-
expressed genes within a module and defines the gene-to-gene rela-
tionship, thus the level of gene connectivity (high/low) (Langfelder
& Horvath, 2008; Langfelder et al, 2013). Genes with high GS values
(ranked by high to low values) were considered highly relevant to
brain size and genes with high GC values (ranked by high to low
values) were considered centrally positioned in the co-expression
network, therefore called hub-genes. The default minimum
number of genes to constitute a module was 30. This threshold
was used to define the top 30 genes that ranked highest using each
network feature (GS and GC), thus providing information on their
central role as relevance to brain (GS) and position within the
network (GC). For instance, high connectivity (hub-genes) was
defined by the highest 30 GC values of a module, while genes not
ranking in the top 30 were deemed of low-connectivity (peripheral)
genes.
Statistical analyses
In our primary analysis, MEs were used in Pearson correlation
tests to identify associations between modules and TBV across all
available subjects. Adjusted P-values (q-values) were calculated
across all 22 modules with the function qvalue() in the WGCNA
package with default settings (lambda = 0,0.90,0.05 and method =
“smoother”). Subsequent correlation tests were run within each
diagnostic group and investigations focused only on modules with
modest to high correlation coefficients (r > 0.3, P < 0.05 and
FDR < 0.05). Bootstrapping on the correlation tests (10,000
resamples) was run to determine 95% confidence intervals around
each correlation estimate. Permutation tests (10,000 iterations)
were run to determine whether the association between MEs and
TBV measures were specific to our dataset or given by chance. To
do so, we scrambled 10,000 times module-color assignment for
each gene and recalculated new module eigengene values (MEs)
on each iteration. We then computed a correlation between ME
and TBV for each of the 10,000 iterations. Finally, we calculated
the P-value as the number of times within the null distribution,
found a correlation as large or larger than the true correlation, and
divided this by 10,001.
Linear modeling of MEs and TBV measures were followed by
ANOVA analyses to test potential age-related effects on MEs signifi-
cantly associated with TBV measures.
Permutation tests (10,000 iterations) were also run to test signifi-
cant difference in correlation strength between ASD and control
groups in ME-TBV correlations. To achieve this, we used a Fisher’s
z transform on the correlation values and computed the difference
score between z-values (zDiff) for each group. Then within the
permutation test, we shuffled group labels randomly, computed
correlations, converted to Fisher’s z, computed zDiff, and then
iterated this entire procedure 10,000 times (each time with a dif-
ferent random shuffling of the group labels). To compute a P-value,
we examined in the null distribution of zDiff values how often were
values as large or larger than the zDiff value computed on the real
(unpermuted) data.
Gene significance P-values for each gene represented in the
networks were calculated using a Student asymptotic test for corre-
lation within the WGCNA package. Quantification of difference
between groups in GS-GC correlations was achieved by computing a
z-statistic for the difference using the paired.r function from the
psych R library. No P-values accompany this statistic because the
statistic reflects the population estimate, given that all genes within
the module are measured. Any z-statistic > 0 here reflects a dif-
ference between groups in GS-GC correlation strength.
Hypergeometric tests were run to establish significant enrich-
ments against random chance in the Hc network and we provide the
P-value as Hyp. P. The background pool total used in these calcula-
tions was 21,405.
Differentially expressed genes (DE; P < 0.05) was performed
as previously described (Pramparo et al, 2015) to identify
differentially expressed (DE) genes using a standard univariate two-
sample t-test model with 10,000 random permutations in BRB-Array
Tools.
Functional enrichment, Hc network and PPI analyses
Pathway enrichment analysis was performed using the Metacore
GeneGo platform, which provides a more extensive hand-curated,
up-to-date gene annotation than available in other freely accessible
sources (Scheiber et al, 2009; Shmelkov et al, 2011). Only enrich-
ments with P-values (P) and FDR < 0.05 have been reported in this
study. Metacore GeneGo was also used to generate a High-
confidence (Hc) network using 33 reported Hc genes (De Rubeis
et al, 2014). A total of 32 out of the 33 Hc genes were present in the
GeneGO database and we used them as seeds to build a network by
selecting the “create network” function, together with “down-
stream” and “by one interaction” options. The resulting Hc network
included 414 genes. This Hc network therefore included subnet-
works in which the 32 Hc genes were the main nodes and other
genes were their direct targets. The Hc network was then color-
coded based on other information.
We used the same strategy to identify to build upstream
networks of the identified 23 candidate genes of brain maldevelop-
ment. We used these 23 genes as seeds and created a network
expanding upstream by one interaction. The list of upstream regula-
tory genes we identified included 106 genes. These were transcrip-
tion factors and gene expression regulators. Subnetworks analysis
followed the same methods used to test significant associations
between MEs and TBV, but here we used the average value of
expression for a subnetwork. Permutation tests (10,000 times) anal-
ogous to those run for testing the between-group difference in ME-
TBV correlation strength were also ran here to test between-group
difference in correlation strength (avg expression value—TBV
measures).
DAPPLE software (http://www.broadinstitute.org/mpg/dapple/
dappleTMP.php) was used for the genetic interaction and
protein–protein interaction analysis using 1,000 permutations and a
common interactor binding degree of 3.
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Data availability
Raw and normalized gene expression data are available at http://
www.ncbi.nlm.nih.gov/geo/ with accession number GSE42133.
Expanded View for this article is available online.
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